Showing results (1041-1050 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|August 4, 2021
Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendrogliomaSirui Ma, Soumon Rudra, Jian L Campian, et al.
Neuro-Oncology Advances|October 21, 2022
The long non-coding RNA SPRIGHTLY and its binding partner PTBP1 regulate exon 5 skipping of SMYD3 transcripts in group 4 medulloblastomasBongyong Lee, Keisuke Katsushima, Rudramani Pokhrel, et al.
Neuro-Oncology Advances|February 22, 2021
Radiogenomic modeling predicts survival-associated prognostic groups in glioblastomaNicholas Nuechterlein, Beibin Li, Abdullah Feroze, et al.
Neuro-Oncology Advances|February 19, 2021
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastomaAxel H Schönthal, David M Peereboom, Naveed Wagle, et al.
Neuro-Oncology Advances|February 25, 2021
Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastomaTiffany S Y Chan, Daniel Picard, Cynthia E Hawkins, et al.
Neuro-Oncology Advances|November 22, 2021
Receptor tyrosine kinases as druggable targets in glioblastoma: Do signaling pathways matter?Anna Qin, Anna Musket, Phillip R Musich, et al.
Neuro-Oncology Advances|November 12, 2021
Glioblastoma cytotoxicity conferred through dual disruption of endolysosomal homeostasis by Vacquinol-1Dongoh Kwak, Lars G J Hammarström, Martin Haraldsson, et al.
Neuro-Oncology Advances|November 12, 2021
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastomaKatja Werlenius, Giuseppe Stragliotto, Michael Strandeus, et al.
Neuro-Oncology Advances|September 8, 2022
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenograftsKendra A Porath, Michael S Regan, Jessica I Griffith, et al.
Neuro-Oncology Advances|September 8, 2022
Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastomaMohamed E El-Abtah, Pratik Talati, Melanie Fu, et al.
Pageof 135